Cytotoxic T lymphocytes (CTL) specific for caprine arthritis-encephalitis virus (CAEV) were characterized using a colorimetric immunocytochemistry assay to measure surviving target cells. Peripheral blood lymphocytes from a CAEV-infected goat were cytotoxic to autologous, CAEV-infected dermal fibroblast target cells following in vitro stimulation of the lymphocytes with CAEV antigen. The lymphocytes were not cytotoxic to infected allogeneic target cells or to mock-infected autologous or allogeneic target cells. This CAEV antigen-specific, major histocompatibility complex-re- 
Introduction
Caprine arthritis-encephalitis virus (CAEV) is a lentivirus that induces chronic progressive disease in goats, primarily arthritis and mastitis (for reviews see Cheevers & McGuire, 1988; McGuire et al., 1990) . Natural infection usually occurs in neonates via colostrum from infected dams. The infection persists for life and clinical disease occurs in some goats after a latent period of months to years. Humoral immune response to viral antigens is associated with the pathogenesis of CAEVinduced arthritis ; however, little is known about the role of host immune reactivity in viral persistence.
In vivo generation of antigenic variants of infecting virus may contribute to persistence of lentivirus infections. Most antigenic variants of CAEV, similar to variants of the human lentivirus (human immunodeficiency virus), have been identified by differences in neutralization-sensitive epitopes of the surface glycoprotein (Ellis et al., 1987; McGuire et al., 1987 McGuire et al., , 1988 Cheevers et aI., 1991; Lichtensteiger et al., 1991) . However, studies with CAEV (Cheevers et al., 1991 virus (Thormar et aI., 1983) , a closely related ovine lentivirus, indicate that these variants persist in the presence of type-specific neutralization antibody suggesting that neutralizing antibody does not control viral persistence.
The contributions of cytotoxic T lymphocytes (CTL) and CTL epitope variability to CAEV persistence and disease pathogenesis are unknown and the present work details initial studies on this subject. We show that (i) major histocompatibility complex (MHC)-restricted, CAEV antigen-specific CTL activity can be detected by measuring surviving target cells using a new colorimetric immunocytochemistry assay, (ii) the cytotoxic effector cells are CD8 + lymphocytes and (iii) the cytotoxic activity of CAEV-specific lymphocytes primed with one CAEV isolate varies against target cells infected with other CAEV isolates.
Methods
Viruses and goats. Six isolates of CAEV, propagated in goat synovial membrane (GSM) cells (Klevjer-Anderson & Cheerers, 1981) , were used. These included the original two CAEV isolates [CAEV-Co (Narayan et al., 1980) and CAEV-63 (Crawford et al., t980) ], which are variants as defined by neutralization epitopes (McGuire et al., 1988) , and also four isolates from 85G28, a goat inoculated with cloned CAEV-63. These four 36.4cR, 42.9fR, 44.9f and 44.9c , are neutralization variants of each other and of CAEV-63. The isolates are designated according to the post-inoculation month of isolation, the tissue source, either joint fluid (f) or joint fluid cells (c) and the joint if an isolate was simultaneously derived from the right (R) and left carpal joint (W. P. Cheevers, L. K. Norton, R. Cody-Cotter, D. P. Knowles Jr & T. C. McGuire, unpublished) .
The five Saanan goats used in this study were obtained from a CAEV-free research breeding herd. Goat 89G38 was inoculated with 106 TCIDs0 CAEV-Co both orally and intravenously at birth and was housed in similar but separate facilities from four naive (uninfected) age-matched control goats. Lymphocytes for CTL assays were collected over a 9 month period starting when the goats were just over 2 years old.
Target cells and effector lymphocytes. Fibroblasts explanted from dermal biopsies from each goat were used as target cells in cytotoxicity assays. The fibroblasts were grown in Dulbecco's MEM supplemented with fetal bovine serum (20% for initial growth; 5% for final passages), expanded by 1:2 passages, and cryopreserved in liquid nitrogen. Dermal fibroblasts were infected with CAEV (2x 10 a TCIDs0/25cm ~ monolayer, approximately 0"1 TCIDso/cell ) or mock-infected 6 days prior to use as target cells.
Effector cells in the cytotoxicity assays were peripheral blood mononuclear cells (PMBC) isolated from heparinized blood using density gradient centrifugation (1.086 specific gravity). The PBMC were used either freshly isolated or following 6 days of in vitro stimulation with CAEV antigen. PBMC were stimulated by coculturing (1.5 x 106 cells/ml medium) with autologous target cells infected 3 days in advance with CAEV-Co (105 TCIDso/25cm ~ monolayer). PBMC were cultured in RPMI-1640 medium supplemented with 10% fetal bovine serum, 10mM-HEPES, 2rm~-Lglutamine, 50 gM-2-mercaptoethanol, penicillin and streptomycin and were incubated in a 37 °C, 5 % CO S chamber. On day 6 of the coculture stimulation, the non-adherent PBMC (lymphocytes) were recovered by gently rinsing and used as effector ceils in cytotoxicity assays.
Immunocytochemical detection of target cells. A monoclonal antibody
(MAb) (see below) was used to evaluate target cells surviving cytotoxic activity of PBMC. Binding of MAb was detected with an avidin-biotin alkaline phosphatase immunocytochemistry assay (ABC-AP immunochemistry). For the immunochemistry, cells in 96-well plates were fixed with methanol: glacial acetic acid (80:1). Non-specific protein binding was blocked with 10 % horse serum and 0-2 % BSA in PBS. Following incubation of the cells with MAb (for 0.5 to 3 h at 4 °C), bound antibody was detected with a commercial ABC-AP immunochemistry system (Vector Laboratories). Two alkaline phosphatase substrates were used: a commercial dye (Vector Laboratories; mixed at three times instruction concentration) forming a red particulate product and p-nitrophenyl phosphate (1.5 mg/ml in 10 mM-MgC12, 100 mMNaHCO 3 buffer; Sigma) forming a soluble product. The antibody reactivity of cells stained with the particulate dye was evaluated microscopically. In the soluble product (cotorimetric) assay, the antibody reactivity was measured by reading the absorbance at 405 nm with a multiwell spectrophotometer (Titertek Multiskan MCC/340; ICN Biomedical). The absorbance readings were not blanked; the culture plate and substrate contributed about 0.080 to the absorbance.
A target cell MAb was selected from hybridomas derived from mice that had been stimulated with six weekly injections of 4-4 x 106 to 12 x 10 n cultured GSM cells. Hybridoma supernatants that reacted with cytoplasmic antigens (fixed cells) but not surface antigens (live ceils) of GSM cells were screened for reactivity with CAEV and mockinfected dermal fibroblast target cells and for no reactivity with freshly isolated PBMC. A hybridoma (RCV508) producing antibody with strong selective binding to target cells was cloned twice by limiting dilution. RCV508 MAb did not bind CAEV antigen-stimulated lymphocytes. The absorbance from RCV508 decreased with serial dilutions of target cells; the decrease was linear with the logarithm of the target cell number at cell numbers from 10000 to 1000, equivalent to a 90 % cell loss ( Colorimetric immunocytochemistry cytotoxicity assay. Ten-thousand target cells were seeded in wells of 96-well plates overnight. Lymphocytes were added to target cells, in replicates of three, at various effector-to-target cell (E:T) ratios and incubated 6 to 8 h. CAEVinfected and native goat lymphocytes were routinely added to both autologous and allogeneic target cells. Target cells without lymphocytes (0:1, control wells) were incubated in parallel. Following incubation, medium was gently aspirated and the cells were fixed, incubated with the target cell MAb (RCV508), and developed for colorimetric ABC-AP immunochemistry. The absorbance from target cells co-incubated with lymphocytes was compared with that from target cells incubated without lymphocytes (0:1, control). A significant decrease (P < 0-01) was determined by analysis of variance and linear contrasts (t test). Decreased values for absorbance of test wells were converted to the number of surviving target cells using least squares regression lines derived from serially diluted target cells incubated without lymphocytes (absorbance versus the logarithm of target cell number). From this number of surviving cells, the percentage of target cells lost due to cytotoxicity was calculated. Background absorbance was monitored by incubating target cells with an isotype control MAb, BABB24C. Following immunochemistry, the soluble substrate was decanted, the wells were stained with Giemsa, and the surviving target cells were inspected microscopically.
CAEV infection of target cells was monitored by detecting CAEV p28 core protein using ABC-AP immunochemistry with a pool of five anti-p28 MAbs (5A1, 8B1, 10A1, 12A1 and 18AI) . The particulate dye was routinely used to verify infection of individual target cells.
Complement depletion of lymphocyte subsets. Lymphocytes were selectively depleted by lysis with MAb plus complement. Cytotoxic lymphocytes were incubated with 5gg/ml anti-CD8 antibody (BAGB25A; Davis et al., 1990b) , combined anti-CD4/anti-N1 (non-CD4/non-CD8/non-B) antibodies (GC50A1/B7A1; Davis et aL, 1990b; Larsen et aL, 1990) , or an isotype control antibody (ColiS52A) for 20 min at 4 °C. Rabbit complement was added, the incubation was then repeated at 37 °C, and lymphocytes were re-isolated by density gradient centrifugation. Following depletion, the subset composition 1987; Larsen et al., 1990) . The MAbs and their specificities are as follows: GC50A1, CD4 T lymphocytes; CACT80C, CD8 T lymphocytes; B7A1, the NI determinant of the WC1 molecule of non-CD4/non-CDS/non-B (N1) lymphocytes; PIg45A, surface IgM of B lymphocytes (Davis et al., , 1990b Larsen et al., 1990) . The anti-CD4 and -CD8 and the anti-N1 and -B antibodies were paired in dual fluorescent staining. Duplicate wells of lymphocytes were stained. Lymphocytes were incubated with isotype control MAb in parallel. The fluorescence of 4000 labelled cells was measured using a flow cytometer (FACScan; Becton Dickinson) and analysed using accompanying software (LYSIS II).
Isolate specificity of cytotoxic lymphocytes. The isolate specificity of CAEV-Co-primed Iymphocytes was investigated by infecting target cells with five CAEV neutralization variants (identified above). All the isolates were cloned by limiting dilution. Virus infection of target cells by the different CAEV isolates was monitored using anti-p28 MAb immunochemistry, and by measuring the percentage of target cells infected using the particulate substrate and assessing the total antigen load using the soluble substrate.
Results

Specific cytotoxicity of CAEV-infected target cells by lymphocytes
CAE goat 89G38 lymphocytes stimulated in vitro with CAEV-Co antigen showed marked cytotoxic activity against autologous target cells infected with CAEV-Co.
The cytotoxic specificity of these lymphocytes at three E: T ratios against both autologous and allogeneic target cells is shown in Fig. 2 . Fig. 2(a) shows results obtained from autologous, infected target cells following incubation with CAEV-infected goat lymphocytes. The absorbance (proportional to target cell number) was significantly reduced from that of target cells incubated alone (0:1, control) at all three lymphocyte E:T ratios. This reduction indicates that 70 % or more of the target cells were lost because of lymphocyte-mediated cytotoxicity. The cytotoxicity was virus-specific in that the mock-infected target cells were not lost and genetically restricted because autologous, but not allogeneic, virusinfected target cells were affected. In vitro stimulated naive goat lymphocytes were not cytotoxic. The immunochemically detected cell loss correlated with Giemsastained surviving target cells values such that few target cells remained in wells with marked cytotoxicity, whereas an uncrowded monolayer of target cells was present in wells with no detected cytotoxicity. An experiment using CAEV-infected goat lymphocytes at lower E:T ratios showed that the percentage of cells lost decreased with decreasing E: T ratios: a 68 % cell loss at 7-5: 1 ratio and a 34 % loss at 2.74: 1 ratio. Cytotoxicity was not detected at 1:1 E:T ratio. Again, cells visualized by Giemsa staining correlated with the amount of cytotoxicity. The CAEV-infected goat stimulated lymphocytes were not cytotoxic to allogeneic target cells from three other goats, providing further evidence for MHC restriction of the cytotoxic lymphocytes. Essentially all target cells in these assays expressed CAEV p28 core antigen, detected by particulate dye immunochemistry, indicating that the lack of cytotoxicity of allogeneic cells was not due to poor infection of target ceils from different goats.
In contrast to lymphocytes stimulated in vitro, there was no cytotoxic activity from freshly isolated PBMC from either CAEV-infected or naive goats.
Effect of CD8 + lymphocyte depletion on cytotoxicity
In vitro stimulation with CAEV antigen enriched CAEV-infected goat PBMC CD8 + lymphocytes levels (data not shown). This CD8 enrichment did not occur in PBMC from naive goats. Also, CAEV antigen was required because the enrichment of CD8 lymphocytes and the development of cytotoxicity did not occur when PBMCs were cultured either alone or with mock-infected autologous target cells instead of with CAEV-infected cells. Many of the stimulated CAE goat CD8 + lymphocytes were enlarged (blast) cells. This selective CD8 enrichment and blast cell formation in CAEV-infected goat PBMC suggested that CD8 lymphocytes were the effector cells. This hypothesis was tested by depleting CD8 + cells with antibody plus complement. The depletion protocol removed 72 % of the CD8 + lymphocytes. Absorbance values for target cells surviving a 6 h co-incubation with CAEV-infected goat stimulated lymphocytes is shown in Fig. 3 . The untreated lymphocytes caused a marked decrease compared to the 0:1 control, indicating that few target cells survived Fig. 3 . Dependence of cytotoxicity on the presence of CD8 + lymphocytes. The absorbance (proportional to the number of target cells) was measured following a 6 h assay of CAEV-infected goat stimulated lymphocytes at a 20: 1 ratio with CAEV-infected autologous target cells. Prior to the cytotoxicity assay, samples of the lymphocytes were subjected to various depletion treatments. Lymphocytes were incubated with no MAb (none), a CD8-specific MAb (CDS), an isotype control MAb (Cntrl), or a mixture of CD4-and Nl-specific MAbs (CD4 + N). The MAb incubation was followed by incubation with (+) or without (-) complement. The no-lymphocyte control (0:1) and the immunochemistry background control (isotype control) for the cytotoxicity assay are the right-most two graph bars. Mean_+s.mM., n=3.
(90-7 + 0-2 % of the target cells were lost). Treatment of the lymphocytes with anti-CD8 + antibody and complement abolished most of the cytotoxic loss (only 16"9 +_ 7-8 % of the target cells were lost). The cytotoxic activity of the lymphocytes was retained in all four depletion control treatments, including combined anti-CD4+/anti-N1 + treatment which depleted all the CD4 + cells and some of the N 1 ÷ cells. The proportion of target cells lost in these control reactions was 90.5 ± 0.4 %. * Percentage calculated based on ABC-AP immunochemistry of autologous, CAEV-infected target cells surviving a 6 h cytotoxicity assay, None, Failure of the lymphocytes to decrease the absorbance below that of target cells incubated alone (0:1 control), P < 0'01. Mean_+ S.mM., n = 3.
t Determined by ABC-AP immunochemistry using a pool of MAbs that recognize CAEV p28 core protein. Positive, the percentage of cells with granules using the particulate dye; Total, the absorbance value obtained using the colorimetric assay. Mean + S.E.M., n = 3.
Activity of cytotoxic lymphocytes against various CAEV isolates
The ability of the CAEV-Co-reactive CTL to cross-react with neutralization variants of CAEV was studied. Lymphocytes were stimulated with CAEV-Co-infected target cells. Target cells were infected with CAEV-Co and five neutralization-sensitive variants. In a 6 h assay, the lymphocytes were cytotoxic to CAEV-Co-infected, autologous target cells at all three E:T ratios (Table 1) . There was no cytotoxic activity against autotogous target cells infected with two of the five CAEV variant isolates. The activity against the other three isolates was lost at different E:T ratios, indicating that cytotoxicity against the isolates varied. There was no apparent correlation between cytotoxic activity and virus infection load of target cells as measured by p28 core antigen expression (Table 1) .
Discussion
The development of a new immunocytochemistry-based cytotoxicity assay measuring surviving target cells facilitated investigation of cell-mediated immunity in goats chronically infected with CAEV. The cytotoxicity assay involved using a MAb with specific reactivity to intracellular antigen of dermal fibroblast target cells to detect CTL-mediated loss of target cells from the monolayer cultures. Loss of adherence of fibroblast target cells is an early, distinct effect of CTL (Russell et al., 1988; Rodgers et al., 1992) . In addition, target cell antigen may be lost from cells through damaged cytoplasmic membrane, similar to the 51Cr release assay, prior to cell detachment. The immunochemical assay avoids the background leakage of 51Cr, which was prohibitively high from the CAEV target cells (data not shown), and also the biohazard of the ~lCr release assay.
CAEV-specific cytotoxicity was limited to autologous target cells indicating that the lymphocyte response was MHC-restricted, a characteristic of CD8 and CD4 lymphocytes, but not of natural killer cells. Some MHC class I allotypes have been identified in goats but not enough to compare haplotypes (van Dam et al., 1979; Nesse & Larsen, 1987; Ruff & Lazary, 1988) . The breeding programme for the research herd is designed to maintain heterogeneity and this is apparently successful since none of the allogeneic control goats presented CAEV antigen on MHC I allotypes in common with the lymphocyte source goat. Subset depletion confirmed that the cytotoxicity was mediated by CD8 lymphocytes, the usual phenotype for MHC I-restricted CTL. We detected no cytotoxic activity by either CD4 lymphocytes or non-CD4/non-CD8/non-B cells, a substantial subset of ruminant PBMC (Davis et al., 1990a) . Except for one preparation the cytotoxicity was consistent in lymphocytes collected 20 times over 9 months.
The CAEV-specific cytotoxicity of lymphocytes for target cells infected with six different CAEV isolates varied substantially based on loss of activity at various E:T ratios. The CTL potentially recognize epitopes on any viral protein, whether core, envelope or regulatory (Lamhamedi-Cherradi et al., 1992; Nixon et aL, 1992) . The number of CTL epitopes expressed on the target cells could not be measured. However, monitoring the CAEV antigen load of target cells with anti-p28 antibodies established that poor infection by some isolates was not responsible for differences in cytotoxicity against target cells infected with the various CAEV isolates. The results suggest that at least some CTL epitopes of CAEV are antigenically variable. Variation of epitopes sensitive to CTL has been identified recently in isolates of the lentivirus human immunodeficiency virus (Takahashi et al., 1989; Phillips et al., 1991 ; Dai et al., 1992; Johnson et al., 1992) . Antigenic changes in CTL epitopes may contribute to loss of host control of virus replication which accompanies the progression of CAEV-induced arthritis (Kle~,jer-Anderson et al., 1984; Knowles et al., 1990) .
Mapping CTL epitopes will contribute to understanding the role of CTL epitope variation in caprine arthritis--encephalitis pathogenesis and vaccine design. CTL epitope variation does not rule out induction of a protective CTL response because a response directed toward conserved regions of lentiviruses is possible (Dadaglio et al., 1991 ; Takahashi et al., 1992; Johnson et al., 1993) .
